Chugai Pharmaceutical Co., Ltd. 4519.T

Name: 4519.T quality scores
Creator: Stocktoria
License: https://stocktoria.com/terms/

JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website

Chugai Pharmaceutical Co., Ltd. (4519.T) earns a Piotroski F-score of 3/9 (weak financial health). It pays a dividend yielding 2.41% (safety: n/a).

3/9

Piotroski F — financial health

—

Altman Z″ — distress risk

—

Dividend payout · n/a

$7,534.00 as of 2026-06-01 · +0.1% 1y

$6,448.00$10,455.0052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap¥12.40T

Dividend yield2.41%

Revenue trend · last 4y · down

How it ranks in Healthcare · percentile among 23 companies

Piotroski Fstronger than 0%

Revenue growthstronger than 74%

Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Positive return on assets
Positive operating cash flow
Rising ROA
Cash flow exceeds net income
Lower long-term debt
Rising current ratio
No share dilution
Rising gross margin
Rising asset turnover

FAQ

Is 4519.T financially healthy?

Chugai Pharmaceutical Co., Ltd.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).

Does 4519.T pay a dividend, and is it safe?

Yes. Chugai Pharmaceutical Co., Ltd. pays a dividend yielding about 2.41% with a None payout ratio, rated “n/a” for safety.

Source: company filings via Yahoo Finance · JP · as of 2025-12-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.